Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Timothy T. Richards is Director at Clearpoint Neuro. OQRO lists 2 transactions filed with the SEC under this name, the latest on Oct 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
1
As of the latest filing on , Timothy T. Richards reported holding 87,863 shares of Clearpoint Neuro (CLPT), worth about $745K at the last close of $8 (Nov 13, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clearpoint Neuro CLPT | 87,863 | 88K direct | $8 | $745K | Oct 1, 2026 |
Is this Timothy T. Richards’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Clearpoint NeuroCLPT
2 disclosures · Jun 2025 – Oct 2026 · 1 sold
Oct 1, 2026319disclosed Oct 2
DetailsOfficial recordJun 10, 2025Sold~$133Kdisclosed Jun 12
DetailsOfficial recordTimothy T. Richards bought shares on the open market in 2015, and has not bought since 2015. Sales in 1 of the 12 years since 2015.
Timothy T. Richards reported 1 open-market purchase and 1 sale since 2015; purchases in 2015.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $133K1×1 trade |
| 2015 | —1×1 trade | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Oct 1, 2026, Timothy T. Richards reported holding 87,863 shares of Clearpoint Neuro (CLPT). At the last close of $8 on Nov 13, 2026, that is about $745K. This is the stake disclosed in filings, not a net worth.
Timothy T. Richards bought shares on the open market in 2015, and has not bought since 2015. Sales in 1 of the 12 years since 2015.
In SEC filings since 2015: the latest open-market purchase is from 2015; the latest open-market sale is from 2025.
Clearpoint Neuro (CLPT), from 2015 to 2025: 1 purchase and 1 sale.
Timothy T. Richards reported 1 open-market purchase and 1 sale here, 2015 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
